Nicholas Schwab

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations.
  2025 L1 78/100

1 assessed by us (1 reproduced) · 126 not yet assessed — every PubMed paper on record, linked below.

• TCR and BCR data supporting the findings of the manuscript "Confined B-cell reconstruction and high T-cell clonality define clinical response to cladribine treatment" by Schneider-Hohendorf et al. 2026 ↗

  Open MIND · 2026
  not yet assessed
• TCR and BCR data supporting the findings of the manuscript "Confined B-cell reconstruction and high T-cell clonality define clinical response to cladribine treatment" by Schneider-Hohendorf et al. 2026 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2026
  not yet assessed
• TCR data supporting the manuscript "T-cell receptor analysis in monozygotic twins discordant for multiple sclerosis: genetic determinants and MS-associated signatures" by Li et al. 2026 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2026
  not yet assessed
• TCR data supporting the manuscript "T-cell receptor analysis in monozygotic twins discordant for multiple sclerosis: genetic determinants and MS-associated signatures" by Li et al. 2026 ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2026
  not yet assessed
• Additional file 1 of Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS ↗

  Figshare · 2026
  not yet assessed
• Additional file 2 of Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS ↗

  Figshare · 2026
  not yet assessed
• Additional file 2 of Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS ↗

  Figshare · 2026
  not yet assessed
• Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS ↗

  Figshare · 2026
  not yet assessed
• Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS ↗

  Figshare · 2026
  not yet assessed
• Additional file 1 of Single-cell analysis of skin and blood reveals systemic immune responses to ultraviolet B and their impairment in MS ↗

  Figshare · 2026
  not yet assessed
• Quelques lépiotes intéressantes ou nouvelles (Agaricaceae, tribu Leucocoprineae) observées dans une serre tropicale en France

  HAL (Le Centre pour la Communication Scientifique Directe) · 2026
  not yet assessed
• A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations

  Journal of Clinical Investigation · 2025 · PMID 39744938
  L1 78/100
• Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome ↗

  JAMA Neurology · 2025 · PMID 40455494
  not yet assessed
• HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis ↗

  EBioMedicine · 2025 · PMID 40749525
  not yet assessed
• B- and T cell receptor sequencing elucidates characteristics of lymphocyte depletion by ocrelizumab ↗

  iScience · 2025 · PMID 40727939
  not yet assessed
• AhR signaling in skin-resident CD207 ⁺ cells is involved in UV-B-induced amelioration of neuroinflammation ↗

  Proceedings of the National Academy of Sciences · 2025 · PMID 40892929
  not yet assessed
• Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and <scp>CSF</scp> Cell Composition ↗

  Annals of Clinical and Translational Neurology · 2025 · PMID 40988462
  not yet assessed
• Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories ↗

  Science Translational Medicine · 2024 · PMID 38536936
  not yet assessed
• Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation ↗

  Brain · 2024 · PMID 39021292
  not yet assessed
• COMPARATIVE ANALYSIS OF T CELL EXPANSION BY BIOREACTOR TYPE: IMPACTS ON PROCESS METRICS AND CELL QUALITY ↗

  Cytotherapy · 2024
  not yet assessed
• Transcriptomics reveals CSF cellular composition in multiple sclerosis but detects no viral RNA ↗

  Brain · 2024 · PMID 38181428
  not yet assessed
• Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response ↗

  Therapeutic Advances in Neurological Disorders · 2023 · PMID 38084102
  not yet assessed
• Learning CNS immunopathology from therapeutic interventions ↗

  Science Translational Medicine · 2023 · PMID 37939164
  not yet assessed
• Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories (P1-3.008) ↗

  Neurology · 2023
  not yet assessed
• A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis ↗

  Science Translational Medicine · 2022 · PMID 36449599
  not yet assessed
• Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis ↗

  The Journal of Experimental Medicine · 2022 · PMID 36048016
  not yet assessed
• Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity ↗

  Brain · 2022 · PMID 35661859
  not yet assessed
• Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis ↗

  Neurology Neuroimmunology & Neuroinflammation · 2022 · PMID 35835563
  not yet assessed
• Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound ↗

  Proceedings of the National Academy of Sciences · 2022 · PMID 36574650
  not yet assessed
• Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies ↗

  Frontiers in Neurology · 2022 · PMID 36588876
  not yet assessed
• Data Sharing and Reuse: A Method by the AIRR Community ↗

  Methods in molecular biology · 2022 · PMID 35622339
  not yet assessed
• Effects of Latitude and Sunlight on Multiple Sclerosis Severity ↗

  Neurology · 2022 · PMID 35410911
  not yet assessed
• Correction: Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis ↗

  The Journal of Experimental Medicine · 2022 · PMID 36305889
  not yet assessed
• The Future of Blood Testing Is the Immunome ↗

  Frontiers in Immunology · 2021 · PMID 33790897
  not yet assessed
• Classification of neurological diseases using multi-dimensional CSF analysis ↗

  Brain · 2021 · PMID 33848319
  not yet assessed
• Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity ↗

  Brain · 2021 · PMID 34849598
  not yet assessed
• Failed reproduction attempt by Biogen due to changed protocols, method of analysis, and poor biomaterial quality

  2021
  not yet assessed
• National Research Data Infrastructure for Immunology (NFDI4Immuno) ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2021
  not yet assessed
• Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity ↗

  Proceedings of the National Academy of Sciences · 2020 · PMID 33376202
  not yet assessed
• Next-Generation Neuroimmunology: New Technologies to Understand Central Nervous System Autoimmunity ↗

  Trends in Immunology · 2020 · PMID 32147112
  not yet assessed
• MCAM/CD146 Signaling via PLCγ1 Leads to Activation of β1-Integrins in Memory T-Cells Resulting in Increased Brain Infiltration ↗

  Frontiers in Immunology · 2020 · PMID 33381120
  not yet assessed
• High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients ↗

  Multiple Sclerosis Journal · 2020 · PMID 33150829
  not yet assessed
• Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity ↗

  medRxiv · 2020
  not yet assessed
• Author response: Prospective validation of the PML risk biomarker <scp>l</scp> -selectin and influence of natalizumab extended intervals ↗

  Neurology · 2020 · PMID 32934158
  not yet assessed
• National Research Data Infrastructure for Adaptive Immune Receptor Repertoires (NFDI4AIRR) ↗

  Zenodo (CERN European Organization for Nuclear Research) · 2020
  not yet assessed
• Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis (1142) ↗

  Neurology · 2020
  not yet assessed
• Characterization of T cells in NMOSD patients - an emerging role for T cells in disease pathogenesis (4017) ↗

  Neurology · 2020
  not yet assessed
• CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome ↗

  Nature Communications · 2019 · PMID 31852955
  not yet assessed
• Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects ↗

  Science Translational Medicine · 2019 · PMID 31043571
  not yet assessed
• Risks and risk management in modern multiple sclerosis immunotherapeutic treatment ↗

  Therapeutic Advances in Neurological Disorders · 2019 · PMID 30967901
  not yet assessed
• Natalizumab-associated progressive multifocal leukoencephalopathy in Germany ↗

  Neurology · 2019 · PMID 30952796
  not yet assessed
• Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis ↗

  Brain · 2019 · PMID 31563951
  not yet assessed
• Ineffective treatment of PML with pembrolizumab ↗

  Neurology Neuroimmunology & Neuroinflammation · 2019 · PMID 31597692
  not yet assessed
• VLA-2 blockade <i>in vivo</i> by vatelizumab induces CD4+FoxP3+ regulatory T cells ↗

  International Immunology · 2019 · PMID 30783682
  not yet assessed
• Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data ↗

  BMC Neurology · 2019 · PMID 31399069
  not yet assessed
• Prospective validation of the PML risk biomarker <scp>l</scp> -selectin and influence of natalizumab extended intervals ↗

  Neurology · 2019 · PMID 31439633
  not yet assessed
• Myalgia with the presence of pathologic EMG correlates with perimysial inflammatory infiltrates ↗

  Neurology Neuroimmunology & Neuroinflammation · 2019 · PMID 41882911
  not yet assessed
• Re:Time to audit all reported PML cases

  2019
  not yet assessed
• Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data ↗

  Research Square · 2019
  not yet assessed
• Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data ↗

  Research Square · 2019
  not yet assessed
• Dietary salt promotes ischemic brain injury and is associated with parenchymal migrasome formation ↗

  PLoS ONE · 2018 · PMID 30589884
  not yet assessed
• Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus ↗

  Journal of Neuroinflammation · 2018 · PMID 30134924
  not yet assessed
• Sex bias in MHC I-associated shaping of the adaptive immune system ↗

  Proceedings of the National Academy of Sciences · 2018 · PMID 29440397
  not yet assessed
• Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid—Results from the ToFingo Successor Study ↗

  Frontiers in Immunology · 2018 · PMID 30050529
  not yet assessed
• Does the environment influence multiple sclerosis pathogenesis via UVB light and/or induction of vitamin D? ↗

  Journal of Neuroimmunology · 2018 · PMID 29793727
  not yet assessed
• Immune Cell Profiling during Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of non-T Cell Populations into the CSF – Results from the ToFingo Successor Study (S52.002) ↗

  Neurology · 2018
  not yet assessed
• Cross-sectional and longitudinal analysis of clinical parameters in a large-scale, national, multicentric multiple sclerosis cohort and the influence of MC1R SNPs ↗

  2018
  not yet assessed
• Natalizumab-associated PML ↗

  Neurology · 2017 · PMID 28228564
  not yet assessed
• Liver X receptor activation promotes differentiation of regulatory T cells ↗

  PLoS ONE · 2017 · PMID 28926619
  not yet assessed
• Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease ↗

  Brain Behavior and Immunity · 2017 · PMID 28642092
  not yet assessed
• Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters ↗

  Multiple Sclerosis Journal · 2017 · PMID 28847222
  not yet assessed
• Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation ↗

  JCI Insight · 2017 · PMID 28768912
  not yet assessed
• Dual action by fumaric acid esters synergistically reduces adhesion to human endothelium ↗

  Multiple Sclerosis Journal · 2017 · PMID 28984166
  not yet assessed
• Analysis of Lymphocyte Extravasation Using an &lt;em&gt;In Vitro&lt;/em&gt; Model of the Human Blood-brain Barrier ↗

  Journal of Visualized Experiments · 2017 · PMID 28448020
  not yet assessed
• Nitazoxanide May Modify the Course of Progressive Multifocal Leukoencephalopathy ↗

  Journal of Clinical Immunology · 2017 · PMID 29159786
  not yet assessed
• Blockade of MCAM on T(H)17 cells impedes their CNS infiltration over the choroid plexus

  mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) · 2017
  not yet assessed
• Analysis of Lymphocyte Extravasation Using an &lt;em&gt;In Vitro&lt;/em&gt; Model of the Human Blood-brain Barrier ↗

  Journal of Visualized Experiments · 2017
  not yet assessed
• Long-term natalizumab treatment enhances the pathogenic signature of Th17 cells – potential implications for treatment cessation? (P2.408) ↗

  Neurology · 2017
  not yet assessed
• Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation ↗

  Proceedings of the National Academy of Sciences · 2016 · PMID 27162345
  not yet assessed
• CD8+ T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing ↗

  Nature Communications · 2016 · PMID 27040081
  not yet assessed
• Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values ↗

  Neurology Neuroimmunology & Neuroinflammation · 2016 · PMID 26848486
  not yet assessed
• Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease ↗

  Science Translational Medicine · 2016 · PMID 27797962
  not yet assessed
• Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets ↗

  Multiple Sclerosis Journal · 2016 · PMID 27481205
  not yet assessed
• CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy ↗

  Neurology · 2016 · PMID 27815407
  not yet assessed
• B7-H1 shapes T-cell–mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity ↗

  Proceedings of the National Academy of Sciences · 2016 · PMID 27671636
  not yet assessed
• CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients ↗

  Neurology · 2016 · PMID 28296380
  not yet assessed
• L-Selektin ist kein zuverlässiger Marker ↗

  InFo Neurologie + Psychiatrie · 2016
  not yet assessed
• Therapy with Natalizumab Is Associated with High JCV Sero-Conversion and Rising JCV Index Values (P2.064) ↗

  Neurology · 2016
  not yet assessed
• Pathogenicity of Rasmussen Encephalitis CD8+ Lymphocytes Elucidated by Large-Scale Sequencing of the T-Cell Receptor Repertoire (P5.242) ↗

  Neurology · 2016
  not yet assessed
• Prospective, multicentric study of using JCV serology and L-selectin for PML risk assessment

  Multiple Sclerosis Journal · 2016
  not yet assessed
• Referee report. For: The TOUCH program and natalizumab: Fundamental flaw in patient protection [version 2; referees: 1 approved, 1 approved with reservations] ↗

  Faculty of 1000 Research Ltd · 2016
  not yet assessed
• Referee report. For: The TOUCH program and natalizumab: Fundamental flaw in patient protection [version 1; referees: 2 approved with reservations] ↗

  Faculty of 1000 Research Ltd · 2016
  not yet assessed
• PML risk stratification using anti-JCV antibody index and L-selectin ↗

  Multiple Sclerosis Journal · 2015 · PMID 26432858
  not yet assessed
• Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor) ↗

  BMC Neurology · 2015 · PMID 26099927
  not yet assessed
• Trafficking of lymphocytes into the CNS ↗

  Oncotarget · 2015 · PMID 26255669
  not yet assessed
• VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells ↗

  The Journal of Experimental Medicine · 2014 · PMID 25135296
  not yet assessed
• Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity ↗

  Annals of Neurology · 2014 · PMID 24771567
  not yet assessed
• Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis ↗

  International Immunology · 2014 · PMID 25326459
  not yet assessed
• Specific loss of cellular L-selectin on CD4+ T cells is associated with progressive multifocal leukoencephalopathy development during HIV infection ↗

  AIDS · 2014 · PMID 24445368
  not yet assessed
• VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells ↗

  Journal of Neuroimmunology · 2014
  not yet assessed
• JCV index and L-selectin for natalizumab-associated PML risk stratification ↗

  Journal of Neuroimmunology · 2014
  not yet assessed
• The pathophysiological role of cytotoxic CD8 T cells in Susac syndrome ↗

  Journal of Neuroimmunology · 2014
  not yet assessed
• UVB light attenuates the systemic immune response in CNS autoimmunity ↗

  Journal of Neuroimmunology · 2014
  not yet assessed
• UVB Light Attenuates the Systemic Immune Response in CNS Autoimmunity (P1.217) ↗

  Neurology · 2014
  not yet assessed
• <scp>l</scp> -Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients ↗

  Neurology · 2013 · PMID 23925765
  not yet assessed
• CD4+NKG2D+ T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation ↗

  PLoS ONE · 2013 · PMID 24282598
  not yet assessed
• Correction: CD4⁺NKG2D⁺T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation ↗

  PLoS ONE · 2013
  not yet assessed
• Fatal PML associated with efalizumab therapy ↗

  Neurology · 2012 · PMID 22302546
  not yet assessed
• CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy ↗

  Neurology · 2012 · PMID 22238416
  not yet assessed
• Immunological and clinical consequences of treating a patient with natalizumab ↗

  Multiple Sclerosis Journal · 2011 · PMID 21908480
  not yet assessed
• Correction: PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation ↗

  PLoS ONE · 2011
  not yet assessed
• Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation ↗

  Blood · 2010 · PMID 20215643
  not yet assessed
• Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis ↗

  European Journal of Immunology · 2010 · PMID 21108477
  not yet assessed
• FOXP3+ T regulatory cells in idiopathic inflammatory myopathies ↗

  Journal of Neuroimmunology · 2010 · PMID 20537411
  not yet assessed
• An Imbalance of Two Functionally and Phenotypically Different Subsets of Plasmacytoid Dendritic Cells Characterizes the Dysfunctional Immune Regulation in Multiple Sclerosis ↗

  The Journal of Immunology · 2010 · PMID 20357264
  not yet assessed
• Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis ↗

  PLoS ONE · 2010 · PMID 21085578
  not yet assessed
• Janus head: the dual role of HLA-G in CNS immunity ↗

  Cellular and Molecular Life Sciences · 2010 · PMID 21086150
  not yet assessed
• CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery ↗

  Brain · 2009 · PMID 19179379
  not yet assessed
• T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible ↗

  Journal of Leukocyte Biology · 2009 · PMID 19401389
  not yet assessed
• Accelerated Course of Experimental Autoimmune Encephalomyelitis in PD-1-Deficient Central Nervous System Myelin Mutants ↗

  American Journal Of Pathology · 2009 · PMID 19443704
  not yet assessed
• Intercellular exchanges of membrane fragments (trogocytosis) between human muscle cells and immune cells: A potential mechanism for the modulation of muscular immune responses ↗

  Journal of Neuroimmunology · 2009 · PMID 19269695
  not yet assessed
• PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation ↗

  PLoS ONE · 2009 · PMID 19197390
  not yet assessed
• The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy ↗

  Neurobiology of Disease · 2008 · PMID 18996482
  not yet assessed
• Human myoblasts modulate the function of antigen-presenting cells ↗

  Journal of Neuroimmunology · 2008 · PMID 18644633
  not yet assessed
• Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice ↗

  Molecular and Cellular Neuroscience · 2007 · PMID 17889554
  not yet assessed
• Effects of somatostatin and captopril on glomerular prostaglandin E2 production in normal and diabetic rats ↗

  Prostaglandins · 1993 · PMID 8104353
  not yet assessed
• Increased renal responsiveness to human atrial natriuretic peptide in patients with active acromegaly ↗

  European Journal of Endocrinology · 1988
  not yet assessed